title: [Primary and secondary prevention of alcoholic liver cirrhosis].
abstract: Alcohol--is the main causative factor of cirrhosis among the population in Russia. The primary prevention must be focused on exception of consumption of heavy doses of alcohol hepatitis and B vaccination. There are no healthy doses of alcohol. Secondary prevention means the use of the hepatoprotectors. List of hepatoprotectors and also amount of money spent to the purchase of these hepatoprotectors increase constantly. But, unfortunately, alongside with it, increases the mortality from hepatic disorders. Effectiveness of the most hepatoprotectors (such as Essential phospholipids, milk thistle) equals to the effectiveness of placebo.
authors.forename: S A
authors.initials: SA
authors.lastname: Beliakin
authors.forename: S V
authors.initials: SV
authors.lastname: Pliusnin
authors.forename: A N
authors.initials: AN
authors.lastname: Bobrov
mesh_terms: D000428:Alcohol Drinking / Q000009:adverse effects; D002986:Clinical Trials as Topic; D006509:Hepatitis B / Q000150:complications; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D010743:Phospholipids / Q000008:administration & dosage / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011322:Primary Prevention / Q000379:methods*; D020011:Protective Agents / Q000008:administration & dosage / Q000145:classification / Q000627:therapeutic use*; D012436:S-Adenosylmethionine / Q000008:administration & dosage / Q000627:therapeutic use; D055502:Secondary Prevention / Q000379:methods*; D012838:Silymarin / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D010743:Phospholipids; D020011:Protective Agents; D012838:Silymarin; D014580:Ursodeoxycholic Acid; D012436:S-Adenosylmethionine